DNM1L and renal cell carcinoma: Immunoblot analysis revealed that tigecycline treatment progressively reduced phosphorylation of dynamin-related protein 1 (DRP1) at serine 616 (p-DRP1 Ser616) in all three RCC cell lines examined (Figure 3A).